News

A pioneering public/private consortium is poised to turn the marathon of drug discovery into a team relay, maybe even a short one.

Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine. Education: Preparing leaders who think critically, work across fields, and lead in rapidly changing marketplaces. PharmD curriculum for 2018 and beyond; Transforming teaching; Coursework in regulatory science and translational medicine; Interdisciplinary exposure. Patient Care: Reframing how medication needs of patients are met. Importance of health information exchange; Outcomes research; Treating patients with more precise medications. People: Supporting our agents of change—our faculty, staff, and alumni. New faculty leaders; Housing and child care; Staff support and engagement; PharmD admissions; Unconscious bias. Framework for Success: Ensuring the School has the framework needed to excel. Support for enabling technology centers; Philanthropic support; Online presence.

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication management; Medicare Part D as a learning model for pharmacy education—impact 10 years out; New genetic insights into diabetes drug response; Annotating the ‘dark genome’; Epigenetics of ethnicity; New endowed professorships made possible by private support; New Center for Cellular Construction; Major funding for UCSF-Stanford CERSI; 2017 Mary Anne Koda-Kimble Seed Award for Innovation; Welcoming the class of 2020; Three generations at the School of Pharmacy; Developing a curriculum for 2018 and beyond; AFPE honors Frank Szoka as Mentor of the Year; 2016 Chancellor Diversity Awards honor Marcus Ferrone and Peace Chukudi; Eddie Way celebrates 100 years; CPhA Hall of Fame honors Brian Komoto, Phillip Oppenheimer, Wilma Wong; $500M gift to campus from Helen Diller Foundation; UC statement on federal executive order restricting travel and entry.

Education: Evolving PharmD curriculum, Daniels Curriculum Awards; Collaborations and partnerships: pharmacy residency, UCSF/Haas MD/PhD startup marketplace; Patient care: SB 493 update; Faculty honors: Benet, Abate, Craik, Wells, Kroon, Corelli, Hudmon, Bourdet, Fischbach; Research publications: genetic testing, pharmacogenomics, cancer, computational tools and modeling (Phillips, Shin, Altschuler and Wu, Sali, Savic); Research funding: Top in NIH funding, protein design, specialty drugs (Kortemme, Stebbins, Cocohoba), QBI (Nevan Krogan), Koda-Kimble Seed Awards; Inclusion: Inequality in health research (Burchard), Black Heritage Month Gala, Post-Baccalaureate program; Alumni: UCSF Alumni Weekend, Distinguished Alumni of the Year (Adler); International: malaria, oncology residency (Chamankha, Yee); Appointments: LeJeune; Media: Desai, Apollonio, Gestwicki; Campus News: Gifts to neuroscience: Dolby Family Fund, Oberndorf Foundation, Weil Family Foundation and Joan and Sanford I. “Sandy” Weill; White House Precision Medicine Summit (Giacomini, Burchard); Cancer Moonshot visit from Vice President Joe Biden (Gartner); Cool Campus Challenge (Beck).